Healthcare Holdco Ltd - Limited company accounts 22.3

Healthcare Holdco Ltd - Limited company accounts 22.3


IRIS Accounts Production v22.4.0.132 08612662 director 31.3.22 1.4.21 31.3.22 31.3.22 a group of dental practices. true true false true true false false false true false Ordinary 1.00000 Ordinary B 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure086126622021-03-31086126622022-03-31086126622021-04-012022-03-31086126622020-03-31086126622020-04-012021-03-31086126622021-03-3108612662ns16:EnglandWales2021-04-012022-03-3108612662ns15:PoundSterling2021-04-012022-03-3108612662ns11:Director12021-04-012022-03-3108612662ns11:Consolidated2022-03-3108612662ns11:ConsolidatedGroupCompanyAccounts2021-04-012022-03-3108612662ns11:PrivateLimitedCompanyLtd2021-04-012022-03-3108612662ns11:FRS102ns11:Consolidated2021-04-012022-03-3108612662ns11:Auditedns11:Consolidated2021-04-012022-03-3108612662ns11:SmallCompaniesRegimeForDirectorsReport2021-04-012022-03-3108612662ns11:SmallCompaniesRegimeForAccounts2021-04-012022-03-3108612662ns11:Consolidatedns11:LargeMedium-sizedCompaniesRegimeForDirectorsReport2021-04-012022-03-3108612662ns11:LargeMedium-sizedCompaniesRegimeForAccountsns11:Consolidated2021-04-012022-03-3108612662ns11:FullAccounts2021-04-012022-03-310861266212021-04-012022-03-3108612662ns11:OrdinaryShareClass12021-04-012022-03-3108612662ns11:OrdinaryShareClass22021-04-012022-03-3108612662ns11:Consolidated2021-04-012022-03-3108612662ns11:RegisteredOffice2021-04-012022-03-3108612662ns11:Consolidated2020-04-012021-03-3108612662ns6:CurrentFinancialInstruments2022-03-3108612662ns6:CurrentFinancialInstruments2021-03-3108612662ns6:ShareCapital2022-03-3108612662ns6:ShareCapital2021-03-3108612662ns6:RetainedEarningsAccumulatedLosses2022-03-3108612662ns6:RetainedEarningsAccumulatedLosses2021-03-3108612662ns6:ShareCapital2020-03-3108612662ns6:RetainedEarningsAccumulatedLosses2020-03-3108612662ns6:RetainedEarningsAccumulatedLosses2020-04-012021-03-3108612662ns6:RetainedEarningsAccumulatedLosses2021-04-012022-03-3108612662ns6:NetGoodwill2021-04-012022-03-3108612662ns6:IntangibleAssetsOtherThanGoodwill2021-04-012022-03-3108612662ns6:LeaseholdImprovements2021-04-012022-03-3108612662ns6:PlantMachinery2021-04-012022-03-3108612662ns6:FurnitureFittings2021-04-012022-03-3108612662ns6:ComputerEquipment2021-04-012022-03-3108612662ns6:FurnitureFittings2021-03-3108612662ns6:ComputerEquipment2021-03-3108612662ns6:FurnitureFittings2022-03-3108612662ns6:ComputerEquipment2022-03-3108612662ns6:FurnitureFittings2021-03-3108612662ns6:ComputerEquipment2021-03-3108612662ns6:CostValuation2021-03-3108612662ns6:WithinOneYearns6:CurrentFinancialInstruments2022-03-3108612662ns6:WithinOneYearns6:CurrentFinancialInstruments2021-03-3108612662ns11:OrdinaryShareClass12022-03-3108612662ns11:OrdinaryShareClass22022-03-31
REGISTERED NUMBER: 08612662 (England and Wales)







Group Strategic Report, Report of the Director and

Consolidated Financial Statements for the Year Ended 31 March 2022

for

Healthcare Holdco Ltd

Healthcare Holdco Ltd (Registered number: 08612662)






Contents of the Consolidated Financial Statements
for the Year Ended 31 March 2022




Page

Company Information 1

Group Strategic Report 2

Report of the Director 3

Report of the Independent Auditors 4

Consolidated Income Statement 8

Consolidated Other Comprehensive Income 9

Consolidated Balance Sheet 10

Company Balance Sheet 11

Consolidated Statement of Changes in Equity 12

Company Statement of Changes in Equity 13

Consolidated Cash Flow Statement 14

Notes to the Consolidated Cash Flow Statement 15

Notes to the Consolidated Financial Statements 16


Healthcare Holdco Ltd

Company Information
for the Year Ended 31 March 2022







DIRECTOR: Dr J S Dhariwal





REGISTERED OFFICE: Walnut Tree House
Court Lane
Burnham
Slough
Buckinghamshire
SL1 8DN





REGISTERED NUMBER: 08612662 (England and Wales)





AUDITORS: Dunkley's Statutory Auditors Chartered Accountants
Woodlands Grange
Woodlands Lane
Bradley Stoke
Bristol
BS32 4JY

Healthcare Holdco Ltd (Registered number: 08612662)

Group Strategic Report
for the Year Ended 31 March 2022

The director presents his strategic report of the company and the group for the year ended 31 March 2022.

REVIEW OF BUSINESS
The Directors are confident about the continuing financial performance of the business and continue to review opportunities provided.

The principal performance indicators used by the board are as follows:
2022 2021
£ £
Turnover 12,174,125 10,090,580
Active branches 19 19
Average turnover per branch 640,743 531,083

PRINCIPAL RISKS AND UNCERTAINTIES
The company seeks to minimise financial risk and appropriate terms are negotiated with lenders, suppliers and . patients. Management reviews the terms and the relationships and manages the exposure as appropriate.

An ongoing risk surrounds the chance of any injuries suffered by patients during dental procedures. The management continuously update safety training and ensure all staff are properly trained to a high level of competency to limit this risk. Other methods designed to reduce this risk to an acceptable level include reviewing any contracted associate dentists, hygienists, locum or similar support to ensure that they maintain the proper continuing professional development, memberships of relevant organisations and insurance cover.

ON BEHALF OF THE BOARD:





Dr J S Dhariwal - Director


31 March 2023

Healthcare Holdco Ltd (Registered number: 08612662)

Report of the Director
for the Year Ended 31 March 2022

The director presents his report with the financial statements of the company and the group for the year ended 31 March 2022.

DIVIDENDS
No dividends will be distributed for the year ended 31 March 2022.

FUTURE DEVELOPMENTS
The group continues to seek new opportunities in which to expand its activities.

DIRECTOR
Dr J S Dhariwal held office during the whole of the period from 1 April 2021 to the date of this report.

FINANCIAL INSTRUMENTS
The company's financial instruments comprise of bank borrowing, cash and liquid resources, and various items such as trade creditors that arise directly from its operations. The main purpose of these financial instruments is to raise finance for the company's operations.

STATEMENT OF DIRECTOR'S RESPONSIBILITIES
The director is responsible for preparing the Group Strategic Report, the Report of the Director and the financial statements in accordance with applicable law and regulations.

Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless he is satisfied that they give a true and fair view of the state of affairs of the company and the group and of the profit or loss of the group for that period. In preparing these financial statements, the director is required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's and the group's transactions and disclose with reasonable accuracy at any time the financial position of the company and the group and enable him to ensure that the financial statements comply with the Companies Act 2006. He is also responsible for safeguarding the assets of the company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the director is aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the group's auditors are unaware, and he has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the group's auditors are aware of that information.

AUDITORS
The auditors, Dunkley's Statutory Auditors Chartered Accountants, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





Dr J S Dhariwal - Director


31 March 2023

Report of the Independent Auditors to the Members of
Healthcare Holdco Ltd

Opinion
We have audited the financial statements of Healthcare Holdco Ltd (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 March 2022 which comprise the Consolidated Income Statement, Consolidated Other Comprehensive Income, Consolidated Balance Sheet, Company Balance Sheet, Consolidated Statement of Changes in Equity, Company Statement of Changes in Equity, Consolidated Cash Flow Statement and Notes to the Consolidated Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the group's and of the parent company affairs as at 31 March 2022 and of the group's profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the director with respect to going concern are described in the relevant sections of this report.

Other information
The director is responsible for the other information. The other information comprises the information in the Group Strategic Report and the Report of the Director, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Group Strategic Report and the Report of the Director for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Group Strategic Report and the Report of the Director have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception
In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group Strategic Report or the Report of the Director.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or
- the parent company financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of director's remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Report of the Independent Auditors to the Members of
Healthcare Holdco Ltd


Responsibilities of director
As explained more fully in the Statement of Director's Responsibilities set out on page three, the director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the director determines necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the director is responsible for assessing the group's and the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the director either intends to liquidate the group or the parent company or to cease operations, or has no realistic alternative but to do so.

Report of the Independent Auditors to the Members of
Healthcare Holdco Ltd


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Extent to which the audit was considered capable of detecting irregularities, including fraud

We identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and then design and perform audit procedures responsive to those risks, including obtaining audit evidence that is sufficient and appropriate to provide a basis for our opinion.

Identifying and assessing potential risks related to irregularities

In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, we considered the following:

- the nature of the industry and sector, control environment and business performance including the design of the company's remuneration policies, bonus levels and performance targets;

- any matters we identified, having obtained and reviewed the company's documentation of their policies and procedures relating to:

o identifying, evaluating and complying with laws and regulations and whether they were aware of any instances of non-compliance;

o detecting and responding to the risks of fraud and whether they have knowledge of any actual, suspected or alleged fraud;

o the internal controls established to mitigate risks of fraud or non-compliance with laws and regulations;

- the matters discussed among the audit engagement team regarding how and where fraud might occur in the financial statements and any potential indicators of fraud.

As a result of these procedures, we considered the opportunities and incentives that may exist within the organisation for fraud and identified the greatest potential for fraud in the areas of management override of controls, and revenue recognition.

We also obtained an understanding of the legal and regulatory framework that the company operates in, focusing on provisions of those laws and regulations that had a direct effect on the determination of material amounts and disclosures in the financial statements.

Audit response to risks identified

Our procedures to respond to risks identified included the following:

- enquiring of management, concerning actual and potential litigation and claims;

- performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud;

- in addressing the risk of fraud through management override of controls, testing the appropriateness of journal entries and other adjustments; assessing whether the judgements made in making accounting estimates are indicative of a potential bias; and evaluating the business rationale of any significant transactions that are unusual or outside the normal course of business.

We also communicated relevant identified laws and regulations and potential fraud risks to all engagement team members, and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Report of the Independent Auditors to the Members of
Healthcare Holdco Ltd


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




M Dobbins FCA (Senior Statutory Auditor)
for and on behalf of Dunkley's Statutory Auditors Chartered Accountants
Woodlands Grange
Woodlands Lane
Bradley Stoke
Bristol
BS32 4JY

31 March 2023

Healthcare Holdco Ltd (Registered number: 08612662)

Consolidated Income Statement
for the Year Ended 31 March 2022

31.3.22 31.3.21
Notes £    £    £    £   

TURNOVER 11,241,672 9,482,362

Cost of sales 5,500,286 3,525,069
GROSS PROFIT 5,741,386 5,957,293

Administrative expenses 4,578,003 3,115,102
1,163,383 2,842,191

Other operating income 139,848 175,740
OPERATING PROFIT 4 1,303,231 3,017,931

Income from interest in associated undertakings 80,000 80,000
Interest receivable and similar income - 13
80,000 80,013
1,383,231 3,097,944

Interest payable and similar expenses 5 500 42,731
PROFIT BEFORE TAXATION 1,382,731 3,055,213

Tax on profit 6 200,558 696,909
PROFIT FOR THE FINANCIAL YEAR 1,182,173 2,358,304
Profit attributable to:
Owners of the parent 1,182,173 2,358,304

Healthcare Holdco Ltd (Registered number: 08612662)

Consolidated Other Comprehensive Income
for the Year Ended 31 March 2022

31.3.22 31.3.21
Notes £    £   

PROFIT FOR THE YEAR 1,182,173 2,358,304


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME FOR THE YEAR 1,182,173 2,358,304

Total comprehensive income attributable to:
Owners of the parent 1,182,173 2,358,304

Healthcare Holdco Ltd (Registered number: 08612662)

Consolidated Balance Sheet
31 March 2022

31.3.22 31.3.21
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 9 797,653 867,915
Tangible assets 10 710,914 589,373
Investments 11 - -
1,508,567 1,457,288

CURRENT ASSETS
Stocks 12 11,700 58,300
Debtors 13 4,070,107 2,726,253
Cash at bank and in hand 2,893,538 2,956,759
6,975,345 5,741,312
CREDITORS
Amounts falling due within one year 14 3,006,913 2,890,227
NET CURRENT ASSETS 3,968,432 2,851,085
TOTAL ASSETS LESS CURRENT LIABILITIES 5,476,999 4,308,373

CREDITORS
Amounts falling due after more than one year 15 (35,833 ) (45,833 )

PROVISIONS FOR LIABILITIES 18 (59,565 ) (63,114 )
NET ASSETS 5,381,601 4,199,426

CAPITAL AND RESERVES
Called up share capital 19 100 100
Retained earnings 20 5,381,501 4,199,326
SHAREHOLDERS' FUNDS 5,381,601 4,199,426

The financial statements were approved by the director and authorised for issue on 31 March 2023 and were signed by:





Dr J S Dhariwal - Director


Healthcare Holdco Ltd (Registered number: 08612662)

Company Balance Sheet
31 March 2022

31.3.22 31.3.21
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 9 - -
Tangible assets 10 3,143 4,038
Investments 11 205,054 205,054
208,197 209,092

CURRENT ASSETS
Debtors 13 3,326,327 3,054,109
Cash at bank 389,205 646,387
3,715,532 3,700,496
CREDITORS
Amounts falling due within one year 14 4,423,443 4,061,823
NET CURRENT LIABILITIES (707,911 ) (361,327 )
TOTAL ASSETS LESS CURRENT LIABILITIES (499,714 ) (152,235 )

CAPITAL AND RESERVES
Called up share capital 19 100 100
Retained earnings (499,814 ) (152,335 )
SHAREHOLDERS' FUNDS (499,714 ) (152,235 )

Company's loss for the financial year (347,479 ) (176,624 )

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 31 March 2023 and were signed by:





Dr J S Dhariwal - Director


Healthcare Holdco Ltd (Registered number: 08612662)

Consolidated Statement of Changes in Equity
for the Year Ended 31 March 2022

Called up
share Retained Total
capital earnings equity
£    £    £   

Balance at 1 April 2020 100 1,845,022 1,845,122

Changes in equity
Dividends - (4,000 ) (4,000 )
Total comprehensive income - 2,358,304 2,358,304
Balance at 31 March 2021 100 4,199,326 4,199,426

Changes in equity
Total comprehensive income - 1,182,173 1,182,173
Balance at 31 March 2022 100 5,381,499 5,381,599

Healthcare Holdco Ltd (Registered number: 08612662)

Company Statement of Changes in Equity
for the Year Ended 31 March 2022

Called up
share Retained Total
capital earnings equity
£    £    £   

Balance at 1 April 2020 100 28,289 28,389

Changes in equity
Dividends - (4,000 ) (4,000 )
Total comprehensive income - (176,624 ) (176,624 )
Balance at 31 March 2021 100 (152,335 ) (152,235 )

Changes in equity
Total comprehensive income - (347,479 ) (347,479 )
Balance at 31 March 2022 100 (499,814 ) (499,714 )

Healthcare Holdco Ltd (Registered number: 08612662)

Consolidated Cash Flow Statement
for the Year Ended 31 March 2022

31.3.22 31.3.21
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 2,270,108 2,802,818
Interest paid (500 ) (42,731 )
Tax paid (541,209 ) (200,000 )
Government grants 117,322 163,089
Net cash from operating activities 1,845,721 2,723,176

Cash flows from investing activities
Purchase of intangible fixed assets (60,270 ) -
Purchase of tangible fixed assets (270,667 ) (103,520 )
Interest received - 13
Dividends received 80,000 80,000
Net cash from investing activities (250,937 ) (23,507 )

Cash flows from financing activities
Loan repayments in year (4,166 ) (653,829 )
Amount withdrawn by directors (472,368 ) 573,058
Movement in loans with related parties (1,181,446 ) (350,799 )
Equity dividends paid - (4,000 )
Net cash from financing activities (1,657,980 ) (435,570 )

(Decrease)/increase in cash and cash equivalents (63,196 ) 2,264,099
Cash and cash equivalents at beginning of year 2 2,956,734 692,635

Cash and cash equivalents at end of year 2 2,893,538 2,956,734

Healthcare Holdco Ltd (Registered number: 08612662)

Notes to the Consolidated Cash Flow Statement
for the Year Ended 31 March 2022

1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS
31.3.22 31.3.21
£    £   
Profit before taxation 1,382,731 3,055,213
Depreciation charges 279,659 266,654
Government grants (117,322 ) (163,089 )
Finance costs 500 42,731
Finance income (80,000 ) (80,013 )
1,465,568 3,121,496
Decrease/(increase) in stocks 46,600 (1,600 )
Increase in trade and other debtors (162,308 ) (260,952 )
Increase/(decrease) in trade and other creditors 920,248 (56,126 )
Cash generated from operations 2,270,108 2,802,818

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 31 March 2022
31.3.22 1.4.21
£    £   
Cash and cash equivalents 2,893,538 2,956,759
Bank overdrafts - (25 )
2,893,538 2,956,734
Year ended 31 March 2021
31.3.21 1.4.20
£    £   
Cash and cash equivalents 2,956,759 692,635
Bank overdrafts (25 ) -
2,956,734 692,635


3. ANALYSIS OF CHANGES IN NET FUNDS

At 1.4.21 Cash flow At 31.3.22
£    £    £   
Net cash
Cash at bank and in hand 2,956,759 (63,221 ) 2,893,538
Bank overdrafts (25 ) 25 -
2,956,734 (63,196 ) 2,893,538
Debt
Debts falling due within 1 year (4,167 ) (5,833 ) (10,000 )
Debts falling due after 1 year (45,833 ) 10,000 (35,833 )
(50,000 ) 4,167 (45,833 )
Total 2,906,734 (59,029 ) 2,847,705

Healthcare Holdco Ltd (Registered number: 08612662)

Notes to the Consolidated Financial Statements
for the Year Ended 31 March 2022

1. STATUTORY INFORMATION

Healthcare Holdco Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the General Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2010, is being amortised evenly over its estimated useful life of five years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - 20% on reducing balance, 20% on cost, Straight line over 3 - 10 years, 10% on cost and over remaining period of lease
Plant and machinery - 33.33% on cost, 20% on reducing balance and 20% on cost
Fixtures and fittings - 20% on reducing balance and 15% on reducing balance
Computer equipment - 33.33% on cost, 33% on reducing balance and 20% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Consolidated Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The group operates a defined contribution pension scheme. Contributions payable to the group's pension scheme are charged to profit or loss in the period to which they relate.

Healthcare Holdco Ltd (Registered number: 08612662)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 March 2022

3. EMPLOYEES AND DIRECTORS
31.3.22 31.3.21
£    £   
Wages and salaries 2,339,409 1,670,292
Social security costs 152,069 116,344
Other pension costs 37,364 22,006
2,528,842 1,808,642

The average number of employees during the year was as follows:
31.3.22 31.3.21

Dental support staff 12 7

The average number of employees by undertakings that were proportionately consolidated during the year was 160 (2021 - 109 ) .

31.3.22 31.3.21
£    £   
Director's remuneration - -

4. OPERATING PROFIT

The operating profit is stated after charging:

31.3.22 31.3.21
£    £   
Other operating leases 270,175 261,923
Depreciation - owned assets 149,126 131,662
Goodwill amortisation 130,532 134,988
Auditors' remuneration 16,500 -

5. INTEREST PAYABLE AND SIMILAR EXPENSES
31.3.22 31.3.21
£    £   
Bank interest 6 42,106
Bank loan interest - 625
Loan 494 -
500 42,731

6. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
31.3.22 31.3.21
£    £   
Current tax:
UK corporation tax 204,126 600,496
Tax under/over provided 43 -
Total current tax 204,169 600,496

Deferred tax (3,611 ) 96,413
Tax on profit 200,558 696,909

Healthcare Holdco Ltd (Registered number: 08612662)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 March 2022

6. TAXATION - continued

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is lower than the standard rate of corporation tax in the UK. The difference is explained below:

31.3.22 31.3.21
£    £   
Profit before tax 1,382,731 3,055,213
Profit multiplied by the standard rate of corporation tax in the UK of 19 % (2021 - 19 %) 262,719 580,490

Effects of:
Expenses not deductible for tax purposes (20,251 ) (15,068 )
Capital allowances in excess of depreciation (41,910 ) -
Depreciation in excess of capital allowances - 161,797
Utilisation of tax losses - (30,310 )
Total tax charge 200,558 696,909

7. INDIVIDUAL INCOME STATEMENT

As permitted by Section 408 of the Companies Act 2006, the Income Statement of the parent company is not presented as part of these financial statements.


8. DIVIDENDS
31.3.22 31.3.21
£    £   
Ordinary shares of £1 each
Interim - 2,000
Ordinary B shares of £1 each
Interim - 2,000
- 4,000

9. INTANGIBLE FIXED ASSETS

Group
Goodwill
£   
COST
At 1 April 2021 3,214,120
Additions 60,270
At 31 March 2022 3,274,390
AMORTISATION
At 1 April 2021 2,346,205
Amortisation for year 130,532
At 31 March 2022 2,476,737
NET BOOK VALUE
At 31 March 2022 797,653
At 31 March 2021 867,915

Healthcare Holdco Ltd (Registered number: 08612662)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 March 2022

10. TANGIBLE FIXED ASSETS

Group
Improvements Fixtures
to Plant and and Computer
property machinery fittings equipment Totals
£    £    £    £    £   
COST
At 1 April 2021 611,209 649,406 172,335 206,987 1,639,937
Additions 56,378 171,860 14,226 28,203 270,667
Disposals - - - (3,930 ) (3,930 )
At 31 March 2022 667,587 821,266 186,561 231,260 1,906,674
DEPRECIATION
At 1 April 2021 407,874 417,455 102,630 122,605 1,050,564
Charge for year 35,440 67,818 15,028 30,840 149,126
Eliminated on disposal - - - (3,930 ) (3,930 )
At 31 March 2022 443,314 485,273 117,658 149,515 1,195,760
NET BOOK VALUE
At 31 March 2022 224,273 335,993 68,903 81,745 710,914
At 31 March 2021 203,335 231,951 69,705 84,382 589,373

Company
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 April 2021 - 5,984 5,984
Additions 940 299 1,239
At 31 March 2022 940 6,283 7,223
DEPRECIATION
At 1 April 2021 - 1,946 1,946
Charge for year 47 2,087 2,134
At 31 March 2022 47 4,033 4,080
NET BOOK VALUE
At 31 March 2022 893 2,250 3,143
At 31 March 2021 - 4,038 4,038

Healthcare Holdco Ltd (Registered number: 08612662)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 March 2022

11. FIXED ASSET INVESTMENTS

Company
Shares in
group
undertakings
£   
COST
At 1 April 2021
and 31 March 2022 205,054
NET BOOK VALUE
At 31 March 2022 205,054
At 31 March 2021 205,054


The following companies are subsidiary undertakings of Healthcare Holdco Ltd.

Each listed undertaking has claimed the exemption from the requirements of the Companies Act 2006 relating to the audit of individual accounts under s479A.


Company name
Company
number

Financialperiod ending
Smile Care Slough 24 Limited 3791579 31 March 2022
Smile Care Cippenham Ltd 8040614 31 March 2022
Smile Care Dorset Ltd 8093687 31 March 2022
Smile Care Paignton Ltd 8144609 31 March 2022
Smile Care Plymouth Ltd 8093748 31 March 2022
Smile Care North Ltd 8040635 31 March 2022
Smile Care Swindon Limited 8289508 31 March 2022
Smile Care (Cornwall) Limited 8763057 31 March 2022
Smile Care (Plymouth City) Limited 8763119 31 March 2022
Smile Care Aberdeen Limited 8788846 31 March 2022
Smile Care South Limited 12189958 31 March 2022
Bodmin Dental Care Limited 6374231 31 March 2022
Dental Careers Limited 10808663 31 March 2022

Each subsidiary company's share capital comprises of 100 £1 shares, and Healthcare Holdco Ltd owns 100% of the share capital.

The registered office address for each subsidiary company is the same as Healthcare Holdco Ltd.

12. STOCKS

Group
31.3.22 31.3.21
£    £   
Stocks 11,700 58,300

Healthcare Holdco Ltd (Registered number: 08612662)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 March 2022

13. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
31.3.22 31.3.21 31.3.22 31.3.21
£    £    £    £   
Trade debtors 658,184 488,684 - -
Amounts owed by group undertakings - - 2,621,818 2,775,008
Other debtors 167,980 179,193 2,000 -
Related party loans 3,217,477 2,035,931 702,509 279,101
Tax 17,258 17,258 - -
Prepayments 9,208 5,187 - -
4,070,107 2,726,253 3,326,327 3,054,109

14. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
31.3.22 31.3.21 31.3.22 31.3.21
£    £    £    £   
Bank loans and overdrafts (see note 16) 10,000 4,192 - -
Trade creditors 901,045 545,618 33,782 29,220
Amounts owed to group undertakings - - 3,846,421 2,989,012
Tax 240,587 577,689 - -
Social security and other taxes 49,250 41,443 7,129 8,689
Other creditors 215,569 164,155 21,901 23,017
Related party loans 521,895 - - -
Related party loans - 521,795 489,948 489,948
Directors' current accounts 45,107 517,475 - 517,475
Accruals and deferred income 679,057 313,509 24,262 4,462
Accrued expenses 344,403 204,351 - -
3,006,913 2,890,227 4,423,443 4,061,823

15. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

Group
31.3.22 31.3.21
£    £   
Bank loans (see note 16) 35,833 45,833

Healthcare Holdco Ltd (Registered number: 08612662)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 March 2022

16. LOANS

An analysis of the maturity of loans is given below:

Group
31.3.22 31.3.21
£    £   
Amounts falling due within one year or on demand:
Bank overdrafts - 25
Bank loans 10,000 4,167
10,000 4,192
Amounts falling due between one and two years:
Bank loans - 1-2 years 10,000 10,000
Amounts falling due between two and five years:
Bank loans - 2-5 years 25,833 30,000
Amounts falling due in more than five years:
Repayable by instalments
Bank loans more 5 yr by instal - 5,833

Loans include:

31.3.22 31.3.21
£ £
Unsecured variable loan of £50,000 repayable on 9 May 2025 45,833 50,000

45,833 50,000

The loan charges variable interest connected to the Bank of England base rate.

17. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Group
Non-cancellable operating leases
31.3.22 31.3.21
£    £   
Within one year 383,273 391,858
Between one and five years 1,234,115 1,405,689
In more than five years 410,897 678,480
2,028,285 2,476,027

18. PROVISIONS FOR LIABILITIES

Group
31.3.22 31.3.21
£    £   
Deferred tax
Accelerated capital allowances 59,565 63,114

Healthcare Holdco Ltd (Registered number: 08612662)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 March 2022

18. PROVISIONS FOR LIABILITIES - continued

Group
Deferred
tax
£   
Balance at 1 April 2021 63,114
Credit to Income Statement during year (3,549 )
Balance at 31 March 2022 59,565

19. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.22 31.3.21
value: £    £   
51 Ordinary £1 51 51
49 Ordinary B £1 49 49
100 100

20. RESERVES

Group
Retained
earnings
£   

At 1 April 2021 4,199,328
Profit for the year 1,182,173
At 31 March 2022 5,381,501


21. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Transactions between group entities which have been eliminated on consolidation are not disclosed within the financial statements.

Key management personnel of the entity or its parent (in the aggregate)
31.3.22 31.3.21
£    £   
Amount due to related party 45,106 517,475

The above balances are unsecured, interest free and repayable on demand.

Other related parties
31.3.22 31.3.21
£    £   
Amount due from related party 3,217,477 2,035,931
Amount due to related party 521,895 521,795

The above balances are unsecured, interest free and repayable on demand.
Other related parties include companies where a director has a participating interest.

Smile Care IOM Limited (incorporated in Isle of Man ) is regarded by the director as being the company's ultimate parent company.